T‐cell replete haploidentical stem cell transplantation with low dose anti‐thymocyte globulin for relapsed/refractory Ewing sarcoma family tumors

T‐cell replete haploidentical stem cell transplantation with low dose anti‐thymocyte globulin for relapsed/refractory Ewing sarcoma family tumors

Abstract Background Despite intensive multimodal therapies, the prognosis of relapsed/ refractory Ewing sarcoma family tumors (RR‐ESFTs) is dismal. Some case reports using allogeneic stem cell transplantation (allo SCT) for RR‐ESFTs have been reported, however, the efficacy of allo SCT is yet to be...

Full description

Bibliographic Details
Main Authors: Hideki Sano, Kazuhiro Mochizuki, Shogo Kobayashi, Yoshihiro Ohara, Nobuhisa Takahashi, Shingo Kudo, Kazuhiko Ikeda, Hitoshi Ohto, Atsushi Kikuta
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Cancer Reports
Subjects:
Ewing sarcoma family tumor
graft versus tumor effect
refractory
relapse
T‐cell replete haploidentical stem cell transplantation
Online Access:https://doi.org/10.1002/cnr2.1519

Internet

https://doi.org/10.1002/cnr2.1519

Similar Items